Mashup Score: 1
Google DocsPage 2 of 102 | IMAGING IN PLASMA CELL DISORDERS (WB DW-MRI) have been extensively studied for monitor- ing response to therapy,8–10 and provided information com- plementary to traditional response assessment. The most recent iteration of response assessment guidelines by the International Myeloma Working Group (IMWG) has ac- knowledged imaging as an integral part of minimal residual disease...
As ASCO23 approaches we all know there will be even more myeloma updates. Let’s not get lost in data and remember the essentials. This is a great review article on how to approach frequency of imaging in plasmacytoma, smoldering MM, and newly diagnosed MM.